Philips’ BlueSeal Magnet is the industry's first and only 1.5T fully sealed magnet that only requires 0.5% of the helium normally needed over the operational lifetime of industry-Synapse Pathology – which is part of Fujifilm’s robust Synapse enterprise imaging portfolio – is a comprehensive pathology PACS solution that streamlines case management through proprietary advances in image digitization to accelerate pathology case turnaround timeMR system magnets

May 4, 2023 — Fujifilm Healthcare Americas Corporation, a leading provider of enterprise imaging and informatics solutions, announced that its Synapse Pathology, the company’s picture archiving and communication system (PACS) for pathology, has won the “Best New Technology Oncology Solution” award in the 7th annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough. MedTech Breakthrough is an independent market intelligence organization that recognizes the top companies, technologies and products in the global health and medical technology market. 

Synapse Pathology – which is part of Fujifilm’s robust Synapse enterprise imaging portfolio – is a comprehensive pathology PACS solution that streamlines case management through proprietary advances in image digitization to accelerate pathology case turnaround time. The solution was designed to seamlessly support the art of precision cancer diagnostics for pathologists. 

The software uses whole slide images from multiple scanning vendors to create a comprehensive solution for digital pathology across laboratories. Synapse Pathology allows laboratories to realize the benefits of workflow efficiencies, centralized imaging records, and enterprise access to images for all clinicians. The system uses an intuitive user interface to put the tools each pathologist needs at their fingertips. The solution also includes an online digital assistant to help pathologists navigate case information and presents tools for measurements, annotations, collaboration, and messaging. Synapse Pathology is the only FDA-cleared pathology solution for primary diagnosis with multiple scanners. 

“We’re honored to be recognized by MedTech Breakthrough for our intelligent tool that is designed to enhance pathology diagnosis, case access and collaboration,” says Bill Lacy, senior vice president, medical informatics, FUJIFILM Healthcare Americas Corporation. “Pathology is one of the last areas in medical imaging to move digital, and as other large imaging service lines like radiology and cardiology are already allowing for rapid image visualization and collaboration across healthcare enterprises, it is now time for pathology to not only accelerate the transition to digital but to also embrace platforms that will enable artificial intelligence adoption within their workflows. As a leader and innovator in enterprise imaging, Fujifilm is well suited to drive the digital pathology transformation.” 

The mission of the MedTech Breakthrough Awards is to honor excellence and recognize the innovation, hard work and success in a range of health and medical technology categories, including Telehealth, Clinical Administration, Patient Engagement, Electronic Health Records (EHR), Virtual Care, Medical Devices, Medical Data and many more. This year’s program attracted more than 4,000 nominations from over 17 different countries throughout the world. 

“The complexity of oncology cases is increasing dramatically, and pathologists are using 120-year-old glass slide methods hoping for interpretable images. New technology that provides insight and expertise is needed, especially for the cancer cases that are getting more complicated with time,” said James Johnson, managing director, MedTech Breakthrough. “Synapse Pathology delivers breakthrough technologies that empower pathologists, allowing them the opportunity to help every patient receive a more rapid and accurate diagnosis. The impact this has on patients alone is a significant breakthrough in a crowded digital health ecosystem. Congratulations on being our pick for the 2023 ‘Best New Oncology Solution’ award.” 

Recently, KLAS Research announced that two of Fujifilm’s Synapse enterprise imaging solutions have been named Best in KLAS in its 2023 Software and Services report. This marks the fourth year in a row that Fujifilm’s Synapse VNA, a core technology for enterprise imaging—and the second consecutive year that the company’s Synapse Radiology PACS (Latin America)—each captured the annual awards in their respective categories. 

For more information: https://healthcaresolutions-us.fujifilm.com


Related Content

News | Digital Pathology

July 24, 2024 — Proscia, a developer of artificial intelligence (AI)-enabled digital pathology solutions for precision ...

Time July 24, 2024
arrow
News | RSNA

July 23, 2024 — Professional registration is open for RSNA 2024, the world’s largest radiology forum. This year’s theme ...

Time July 23, 2024
arrow
News | Artificial Intelligence

July 23, 2024 — Researchers at the National Institutes of Health (NIH) found that an artificial intelligence (AI) model ...

Time July 23, 2024
arrow
News | Digital Pathology

July 12, 2024 — AGFA HealthCare, a global leader in healthcare imaging management solutions, announced that Enterprise ...

Time July 12, 2024
arrow
News | Digital Pathology

July 12, 2024 — Diagnosing cancer and providing the personalized therapy it often requires, is a collaborative effort ...

Time July 12, 2024
arrow
Feature | Imaging Technology News - ITN

Be sure to check out the latest digital edition of Imaging Technology News (ITN), featuring the Mobile C-arm Systems ...

Time July 11, 2024
arrow
Feature | PACS | By Michael J. Cannavo

Back in 1966, Joni Mitchell sang these words in her song “Both Sides Now:” I’ve looked at clouds from both sides now ...

Time July 08, 2024
arrow
Feature | Radiology Business

ITN conducts a bi-monthly survey to its readers on a variety of topics, which is used to create the Last Read, a unique ...

Time July 08, 2024
arrow
Feature | Radiology Business

The ITN team wishes you a safe and happy 4th of July!

Time July 04, 2024
arrow
News | Artificial Intelligence

July 3, 2024 — Proscia, a global leader in AI-enabled pathology solutions for precision medicine, has partnered with ...

Time July 03, 2024
arrow
Subscribe Now